Medicenna Advances MDNA11 Melanoma Trial in Italy
TORONTO, Ontario, May 13, 2026 Medicenna Therapeutics announced that the first patient has been enrolled and dosed in the...
Cancer Research
Advertisement
Merck Unveils Major Oncology Advances at ASCO 2026
RAHWAY, N.J., May 12, 2026 Merck announced a major expansion of its oncology research portfolio ahead of the 2026...
Servier Advances OJEMDA Front-Line Brain Cancer Trial
BOSTON – May 8, 2026 Day One Biopharmaceuticals, now part of Servier Group, announced the completion of patient enrollment...
Guardant Health, Nuvalent Partner in Precision Oncology
Palo Alto, USA | April 30, 2026 Guardant Health and Nuvalent have announced a multi-year strategic collaboration to develop...
MediciNova Advances Brain Metastasis Therapy With MN-166
LA JOLLA, Calif., April 27, 2026 MediciNova, Inc. has announced a major scientific breakthrough in the treatment of brain...
Advertisements
City of Hope Unveils AI and Cancer Breakthroughs at AACR
LOS ANGELES, April 16, 2026 City of Hope announced that its scientists will present groundbreaking research findings on cancer...
NeoGenomics Advances AI-Driven Oncology Insights at AACR
Fort Myers, Florida | April 13, 2026 NeoGenomics, Inc. has announced the presentation of multiple scientific abstracts at the...
Adagene Reports Strong Muzastotug KEYTRUDA CRC Data
San Diego, USA & Suzhou, China, April 2, 2026 Strong Clinical Efficacy in MSS Colorectal Cancer In a major...
IDEAYA Biosciences Doses First Patient in IDE574 Trial
South San Francisco, California, USA, April 6, 2026 First-in-Class Epigenetic Therapy Enters Clinical Development In a major step forward...
Akeso Cadonilimab Combo Delivers Strong NSCLC Trial Results
Hong Kong, April 6, 2026 Promising Results in Immunotherapy-Resistant NSCLC In a significant advancement for lung cancer immunotherapy, Akeso,...
Advertisement
